MEFV and PFAPA syndrome: Taken together, colchicine treatment should be considered for PFAPA patients with moderate to high disease activity, including those with increased disease activity/shortening of symptom-free intervals due to corticosteroids, even in the absence of MEFV gene variants as excellent effectiveness is consistently documented.